Mitochondrial & Metabolic

MOTS-c

For Research Use Only. Not for Human or Veterinary Use.

Overview

MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial 12S ribosomal RNA gene. In preclinical research it has emerged as a regulator of metabolic homeostasis, insulin sensitivity and exercise physiology, and is often described as an “exercise-mimetic” peptide because it activates the same AMPK-centred stress signalling that exercise does. It is a research compound.

Chemical Profile

PropertyValue
CAS number1626405-30-4
ClassMitochondrial-derived peptide (MDP)
Encoding geneMitochondrial 12S rRNA (MT-RNR1)
Amino-acid sequenceH-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH
One-letter codeMRWQEMGYIFYPRKLR (16 aa)
Molecular weight≈ 2174.6 g/mol
Purity (HPLC)≥ 98%
AppearanceWhite to off-white lyophilized powder
MOTS-c at a glance
Class
Mitochondrial-derived peptide
Gene
Mitochondrial 12S rRNA (MT-RNR1)
Research status
Preclinical metabolic research
Study routes
SC, intraperitoneal
Half-life
≈ 2–4 h (estimated)
Key feature
Exercise-mimetic, insulin-sensitizing

Mechanism of Action

MOTS-c is a peptide encoded inside mitochondrial DNA that, under metabolic stress, moves to the nucleus and influences stress-responsive gene expression. It is studied as an indirect AMPK activator — the master energy sensor — which links it to the metabolic effects usually associated with exercise.

ComponentDetail
Primary targetAMPK (indirect), folate–methionine metabolism
AMPK activationVia altered folate metabolism and AICAR accumulation
Insulin signallingStudied for enhanced IRS-1/Akt activation and glucose uptake
Gene regulationNuclear translocation; regulates stress genes (AP-1)
FGF21 inductionUpregulation linked to an exercise-like metabolic response
Mitochondrial stress responseActivates the mitochondrial unfolded-protein response (UPRmt)
SystemStudied effect
Skeletal muscleGlucose uptake and fatty-acid oxidation (AMPK, GLUT4)
Adipose tissueBrowning and thermogenesis (FGF21, UCP1)
LiverReduced steatosis, improved insulin sensitivity
AgingAmelioration of age-dependent insulin resistance in models

Pharmacology

ParameterValue
Half-life (t½)≈ 2–4 h (plasma, estimated)
Bioavailability (SC)≈ 50–70% (estimated)
Protein bindingModerate
MetabolismProteolytic degradation
Route of administrationSC, intraperitoneal (research)
EliminationRenal (peptide fragments)

Research Evidence

MOTS-c research is at the preclinical stage, mostly in rodent metabolic models. Representative studies and their focus are named below; specific numerical outcomes are not restated here as claims.

ModelResearch focusReference
High-fat-diet miceInsulin resistance and glucose toleranceLee C, et al. (2015)
Aged miceMetabolic function and exercise capacityReynolds JC, et al. (2020)
Skeletal-muscle cellsAMPK activation and fatty-acid oxidationMOTS-c preclinical literature
NASH mouse modelHepatic steatosis and inflammationMOTS-c preclinical literature

Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):

Reported direction / findingContextReference
Improved insulin sensitivity and glucose tolerancehigh-fat-diet miceLee C et al., 2015
Enhanced exercise capacity in aged animalsaged miceReynolds JC et al., 2020
AMPK-mediated metabolic (exercise-mimetic) effectsskeletal-muscle cellsMOTS-c literature

For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.

Dosing & Reconstitution Reference

Reconstitution and handling parameters for laboratory research. Not dosing guidance for human use.

ParameterReference value
Research dose range (literature)≈ 5–15 mg per injection, 1–2× weekly, in study protocols
Reconstitution solventBacteriostatic water (0.9% benzyl alcohol)
Final concentration≈ 5–10 mg/mL
Storage (lyophilized)−20°C, protected from light
Storage (reconstituted)2–8°C, up to ~7 days
Do not useIf the solution is cloudy or contains particulates

Safety Profile

Published research observations, provided for reference only. This material is not for human or veterinary use.

CategoryPublished observations
Local tolerabilityMild injection-site reactions
CytotoxicityNo cytotoxicity observed in cell-based assays
GenotoxicityNegative in standard assays
GlucoseInsulin-sensitizing signal; glucose is monitored in models
StatusFor research use only; not for human or veterinary application

Physicochemical Properties

PropertyValue
Physical stateWhite to off-white lyophilized powder
Solubility (water)Freely soluble (> 50 mg/mL)
logP (octanol/water)≈ −2.1 (hydrophilic)
Isoelectric point (pI)≈ 12 (basic, arginine-rich)
pH (reconstituted)5.0–6.0
Stability (lyophilized)≥ 24 months at −20°C

Synthesis & Manufacturing

MOTS-c is produced by Fmoc solid-phase peptide synthesis. The arginine-rich sequence makes coupling of the basic residues the step that needs the most care.

StepDetail
StrategyFmoc solid-phase peptide synthesis
ResinRink amide MBHA resin
CouplingHBTU / HOBt with DIPEA; double coupling for arginine residues
CleavageTFA / TIPS / H₂O (95 : 2.5 : 2.5)
PurificationPreparative RP-HPLC (C18, TFA/ACN gradient)
  • Notes: coupling efficiency and complete Fmoc removal are monitored each cycle; hindered or repeated residues (e.g. Arg-Arg) may need double coupling.
  • Preparative RP-HPLC removes deletion and truncation impurities to reach research-grade purity; salt exchange (lyophilization from dilute HCl) removes residual TFA/acetate.
  • Critical quality attributes: correct molecular weight and low deletion-peptide content. Arginine-rich sequence with two methionines — confirm absence of deletion peptides and control oxidation.

Analytical Methods

MethodParameterTypical result
RP-HPLC (C18, UV 214 nm)Purity≥ 98%
HPLC retentionC18, 10–40% B over 25 minSingle main peak
ESI-MS (positive mode)Identity / massconsistent with the 16-residue peptide
MALDI-TOFMass confirmationconsistent with the 16-residue peptide
Amino-acid analysisCompositionConsistent with the stated sequence
LC-MS (extracted ion)Deletion-peptide impuritiesWithin specification
Karl FischerWater content< 6%
LAL assayEndotoxinWithin specification
Ion chromatographyResidual TFA< 500 ppm

Representative RP-HPLC purity method:

  • Column: C18, 5 µm, 250 × 4.6 mm
  • Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
  • Gradient: 10–40% B over 25 min · Flow rate: 1.0 mL/min · Detection: UV 214 nm
  • Confirmatory LC-MS: ESI positive mode (consistent with the 16-residue peptide). Arginine-rich sequence with two methionines — confirm absence of deletion peptides and control oxidation.

Stability Data

Representative stability behaviour under common storage, handling and formulation conditions.

ConditionDurationResult
Lyophilized, −20°C, dark≥ 24 monthsNo significant degradation (purity > 97%)
Lyophilized, 2–8°C, dark≥ 12 monthsMinimal degradation (purity > 95%)
Lyophilized, 25°C (accelerated)3 months< 5% degradation
Reconstituted, 2–8°C, dark7–14 daysMinor degradation
Reconstituted, 25°C24–48 hUse promptly
Light exposure (ICH Q1B)1.2 M lux·hGenerally light-stable
Freeze–thaw (−20°C ⇄ 25°C)3 cyclesAcceptable — aliquot to avoid repeats
  • Keep lyophilized powder cold, dry and light-protected; keep any solution refrigerated and protected from light.
  • Minimise freeze-thaw cycles; aliquot material used across many sessions.
  • Key factor: Arginine-rich sequence with two methionines — confirm absence of deletion peptides and control oxidation.

Selected References

  • Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015.
  • Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2020.
  • Kim KH, et al. Mitochondrial-derived peptides in aging and metabolic regulation (review literature).

Quality & Supply

  • HPLC ≥ 98% purity with a Certificate of Analysis per batch
  • Identity confirmed by LC-MS
  • Research samples through to bulk, with worldwide delivery
  • Custom quantities and packaging on request

Need MOTS-c — sample or bulk?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote